RUSSELL MUELLER for PKD FOUNDATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Obtain extension of immunosuppressive drug provisions under federal health programs via hte Senate version of health reform legislation, H.R. 3590, the Patient Protection and Affordable Care Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RUSSELL J MUELLER | — |
Medical/Disease Research/Clinical Labs MED
Obtained mention of PKD in Senate FY2010 Defense appropriations bill for research and clinical funding under Defense Peer Reviewed Medical Research Program (Senate version of H.R. 3326); Obtained report language for PKD forum and clinical treatment centers under FY2010 HHS/NIH/NIDDK appropriations House and Senate bills, H.R. 3293, as passed as part of Consolidated Appropriations Act, H.R. 3288, and obtained funding for PKD education efforts under H.R. 3293 and H.R 3288.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RUSSELL J MUELLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.